| Literature DB >> 33464307 |
Zhen Zhuang1, Xiaomin Lai1, Jing Sun1, Zhao Chen1, Zhaoyong Zhang1, Jun Dai2, Donglan Liu1, Yuming Li1, Fang Li1, Yanqun Wang1, Airu Zhu1, Junxiang Wang1, Wenhui Yang3, Jicheng Huang2, Xiaobo Li2, Lingfei Hu3, Liyan Wen1, Jianfen Zhuo1, Yanjun Zhang1, Dingbin Chen1, Suxiang Li1, Shuxiang Huang2, Yongxia Shi2, Kui Zheng2, Nanshan Zhong1, Jingxian Zhao1, Dongsheng Zhou3, Jincun Zhao1,4.
Abstract
Virus-specific T cells play essential roles in protection against multiple virus infections, including SARS-CoV and MERS-CoV. While SARS-CoV-2-specific T cells have been identified in COVID-19 patients, their role in the protection of SARS-CoV-2-infected mice is not established. Here, using mice sensitized for infection with SARS-CoV-2 by transduction with an adenovirus expressing the human receptor (Ad5-hACE2), we identified SARS-CoV-2-specific T cell epitopes recognized by CD4+ and CD8+ T cells in BALB/c and C57BL/6 mice. Virus-specific T cells were polyfunctional and were able to lyse target cells in vivo. Further, type I interferon pathway was proved to be critical for generating optimal antiviral T cell responses after SARS-CoV-2 infection. T cell vaccination alone partially protected SARS-CoV-2-infected mice from severe disease. In addition, the results demonstrated cross-reactive T cell responses between SARS-CoV and SARS-CoV-2, but not MERS-CoV, in mice. Understanding the role of the T cell response will guide immunopathogenesis studies of COVID-19 and vaccine design and validation.Entities:
Year: 2021 PMID: 33464307 DOI: 10.1084/jem.20202187
Source DB: PubMed Journal: J Exp Med ISSN: 0022-1007 Impact factor: 14.307